モンテルカストナトリウムの世界市場レポート 2024年

モンテルカストナトリウム市場規模は、今後数年間で力強い成長が見込まれます。2028年にはCAGR9.7％で55億9,000万米ドルに成長します。予測期間中に予想される成長は、承認・上市、臨床試験、特許切れ、規制シフト、医師の処方パターンにまで遡ることができます。予測期間中に予測される注目すべき動向には、ジェネリック医薬品の競争激化、競合治療への移行、新興市場での拡大、小児用途への集中、デジタルヘルスソリューションの統合などが含まれます。

喘息の有病率の上昇が、今後のモンテルカストナトリウム市場の成長を牽引すると予測されます。喘息は、気道の炎症と狭窄を特徴とする慢性呼吸器疾患であり、喘鳴、息苦しさ、胸部圧迫感、咳の再発を引き起こします。喘息有病率の増加は、環境汚染、アレルゲンへの暴露、遺伝的素因、都市化、ライフスタイルの変化、呼吸器感染症などの要因によるものです。ロイコトリエン受容体拮抗薬であるモンテルカストナトリウムは、気道の炎症や収縮に関与するロイコトリエンの作用を阻害することにより、症状を予防・緩和する喘息管理に利用されています。例えば、2022年9月の国民保健サービス（NHS）によると、イングランドとウェールズにおける喘息児の入院数は、2021～2022年の間に149％急増しました。喘息の症状で入院した幼児の数は、2020～2021年の期間には7,850人であったのに対し、1万9,506人に増加しました。その結果、喘息の有病率の増加がモンテルカストナトリウム市場の拡大に拍車をかけています。

モンテルカストナトリウム市場の主要企業は、製品ラインナップを拡充し、アレルギー疾患患者のニーズの変化に対応するため、塩酸フェキソフェナジンなどの新薬開拓を積極的に進めています。フェキソフェナジン塩酸塩は、成人と小児のアレルギー症状や花粉症に対してFDAから承認された第2世代の抗ヒスタミン薬で、こうした新薬のひとつです。例えば、Morepen Laboratoriesは2021年12月、抗アレルギー薬のジェネリック医薬品である塩酸フェキソフェナジンを米国で販売するためのFDA承認を取得しました。この承認は、Morepen Laboratoriesにとって重要なマイルストーンであり、抗アレルギー市場での地位を強化するものです。

目次

第1章 エグゼクティブ概要

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界の市場規模と成長

• 世界のモンテルカストナトリウム市場：促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界のモンテルカストナトリウム市場の実績：規模と成長、2018～2023年
• 世界のモンテルカストナトリウム市場の予測：規模と成長、2023～2028年、2033年

第6章 市場セグメンテーション

• 世界のモンテルカストナトリウム市場：製品別、実績と予測、2018～2023年、2023～2028年、2033年
• 結晶状
• 無定形または不定形
• 世界のモンテルカストナトリウム市場：剤形別、実績と予測、2018～2023年、2023～2028年、2033年
• 錠剤
• 経口溶液
• 世界のモンテルカストナトリウム市場：用途別、実績と予測、2018～2023年、2023～2028年、2033年
• 気管支けいれん
• アレルギー性鼻炎
• 喘息
• 蕁麻疹
• その他

第7章 地域別・国別分析

• 世界のモンテルカストナトリウム市場：地域別、実績と予測、2018～2023年、2023～2028年、2033年
• 世界のモンテルカストナトリウム市場：国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• モンテルカストナトリウム市場：競合情勢
• モンテルカストナトリウム市場：企業プロファイル
  • Pfizer Inc.
  • Merck & Co. Inc.
  • Sanofi Aventis SA
  • Teva Pharmaceuticals USA Inc.
  • Hetero Labs Ltd.

第31章 その他の大手企業と革新的企業

• Sun Pharma Industries Ltd.
• Aurobindo Pharma Limited
• Cipla Inc.
• Intas Pharmaceuticals Ltd.
• Seqens Group
• Sanyo Chemical Industries Ltd.
• Morepen Laboratories
• Neuland Laboratories Ltd.
• Medopharm Private Ltd.
• BEC Chemicals Pvt. Ltd
• Delmar Chemicals Inc.
• Kimia Biosciences Ltd.
• Ortin Laboratories Ltd.
• MSN Laboratories Pvt Ltd.
• Vamsi Labs Ltd.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在的な分析

第36章 付録

Montelukast sodium functions as a leukotriene receptor antagonist, blocking the action of leukotrienes that induce asthma symptoms and allergic reactions. It is employed for managing and preventing asthma symptoms and alleviating seasonal and perennial allergic rhinitis. Typically, montelukast is administered orally in tablet form.

Montelukast sodium exists in several product types, including crystal-like, form-less, or amorphous variations. Crystal-like denotes a solid substance with a regular, repeating three-dimensional arrangement of its atoms or molecules. Different dosage forms such as tablets and oral solutions are utilized for various applications, including bronchospasm, allergic coryza, asthma, urticaria, among others.

The montelukast sodium market research report is one of a series of new reports from The Business Research Company that provides montelukast sodium market statistics, including montelukast sodium industry global market size, regional shares, competitors with a montelukast sodium market share, detailed montelukast sodium market segments, market trends, and opportunities, and any further data you may need to thrive in the montelukast sodium industry. This montelukast sodium market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The montelukast sodium market size has grown strongly in recent years. It will grow from $3.52 billion in 2023 to $3.86 billion in 2024 at a compound annual growth rate (CAGR) of 9.6%. The rise during the historical era can be credited to the escalation of respiratory disorders, an aging demographic, heightened levels of air pollution, expanding awareness and education, and the advancement of emerging markets.

The montelukast sodium market size is expected to see strong growth in the next few years. It will grow to $5.59 billion in 2028 at a compound annual growth rate (CAGR) of 9.7%. Anticipated growth in the forecasted period can be traced back to approvals and launches, clinical investigations, patent expirations, regulatory shifts, and the prescribing patterns of physicians. Notable trends projected for the forecast period encompass heightened generic competition, a transition toward combination therapies, expansion in emerging markets, a concentration on pediatric application, and the integration of digital health solutions.

The rising prevalence of asthma is anticipated to drive the growth of the montelukast sodium market in the future. Asthma is a chronic respiratory disorder characterized by inflammation and narrowing of the airways, leading to recurrent episodes of wheezing, breathlessness, chest tightness, and coughing. The increase in asthma prevalence is attributed to factors such as environmental pollution, allergen exposure, genetic predisposition, urbanization, lifestyle changes, and respiratory infections. Montelukast sodium, a leukotriene receptor antagonist, is utilized in asthma management to prevent and alleviate symptoms by inhibiting the action of leukotrienes, which contribute to airway inflammation and constriction. For example, according to the National Health Service (NHS) in September 2022, hospital admissions for children with asthma in England and Wales surged by 149% between 2021 and 2022. The number of children admitted with asthma symptoms increased to 19,506, compared to 7,850 during the 2020 to 2021 period. Consequently, the growing prevalence of asthma is fueling the expansion of the montelukast sodium market.

Major players in the montelukast sodium market are actively pursuing the development of new medications such as fexofenadine hydrochloride to broaden their product offerings and cater to the changing needs of patients with allergic conditions. Fexofenadine hydrochloride, a second-generation antihistamine approved by the FDA for allergy symptoms and hay fever in both adults and children, is among these new drugs. For example, Morepen Laboratories received FDA approval in December 2021 to market its generic anti-allergy medication, Fexofenadine Hydrochloride, in the United States. This approval marks a significant milestone for Morepen Laboratories, reinforcing its position in the anti-allergy market.

In April 2023, SK Capital Partners LP, a US-based private investment firm, completed the acquisition of Apotex Pharmaceutical Holdings Inc. for an undisclosed sum. This acquisition bolsters SK Capital's presence in the pharmaceutical sector, granting it access to Apotex's extensive global operations, product portfolio, and skilled workforce. Apotex Pharmaceutical Holdings Inc., headquartered in Canada, is known for manufacturing montelukast sodium and engaging in commercial physical and biological research and development.

Major companies operating in the montelukast sodium market are Pfizer Inc., Merck & Co. Inc., Sanofi Aventis SA, Teva Pharmaceuticals USA Inc., Hetero Labs Ltd., Sun Pharma Industries Ltd., Aurobindo Pharma Limited, Cipla Inc., Intas Pharmaceuticals Ltd., Seqens Group, Sanyo Chemical Industries Ltd., Morepen Laboratories, Neuland Laboratories Ltd., Medopharm Private Ltd., BEC Chemicals Pvt. Ltd, Delmar Chemicals Inc., Kimia Biosciences Ltd., Ortin Laboratories Ltd., MSN Laboratories Pvt Ltd., Vamsi Labs Ltd., LGM Pharma LLC, HRV Global Life Sciences, Sigmak Lifesciences, Akums Lifesciences Ltd., Anwita Drugs & Chemicals Pvt Ltd

North America was the largest region in the montelukast sodium market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the montelukast sodium market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the montelukast sodium market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The montelukast sodium market consists of sales of monteluksast oral granules, chewable tablets, pill organizers, dosing spoons and syringes, and tablet packaging material. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Montelukast Sodium Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on montelukast sodium market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for montelukast sodium ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The montelukast sodium market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Crystal-like; Form-less Or Amorphous
• 2) By Dosage Form: Tablets; Oral Solutions
• 3) By Application: Bronchospasm; Allergic Coryza; Asthma; Urticaria; Other Applications
• Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; Sanofi Aventis SA; Teva Pharmaceuticals USA Inc.; Hetero Labs Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Montelukast Sodium Market Characteristics

3. Montelukast Sodium Market Trends And Strategies

4. Montelukast Sodium Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Montelukast Sodium Market Size and Growth

• 5.1. Global Montelukast Sodium Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Montelukast Sodium Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Montelukast Sodium Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Montelukast Sodium Market Segmentation

• 6.1. Global Montelukast Sodium Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Crystal-like
• Form-less Or Amorphous
• 6.2. Global Montelukast Sodium Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Tablets
• Oral Solutions
• 6.3. Global Montelukast Sodium Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Bronchospasm
• Allergic Coryza
• Asthma
• Urticaria
• Other Applications

7. Montelukast Sodium Market Regional And Country Analysis

• 7.1. Global Montelukast Sodium Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Montelukast Sodium Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Montelukast Sodium Market

• 8.1. Asia-Pacific Montelukast Sodium Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Montelukast Sodium Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Montelukast Sodium Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Montelukast Sodium Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Montelukast Sodium Market

• 9.1. China Montelukast Sodium Market Overview
• 9.2. China Montelukast Sodium Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Montelukast Sodium Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Montelukast Sodium Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Montelukast Sodium Market

• 10.1. India Montelukast Sodium Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Montelukast Sodium Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Montelukast Sodium Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Montelukast Sodium Market

• 11.1. Japan Montelukast Sodium Market Overview
• 11.2. Japan Montelukast Sodium Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Montelukast Sodium Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Montelukast Sodium Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Montelukast Sodium Market

• 12.1. Australia Montelukast Sodium Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Montelukast Sodium Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Montelukast Sodium Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Montelukast Sodium Market

• 13.1. Indonesia Montelukast Sodium Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Montelukast Sodium Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Montelukast Sodium Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Montelukast Sodium Market

• 14.1. South Korea Montelukast Sodium Market Overview
• 14.2. South Korea Montelukast Sodium Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Montelukast Sodium Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Montelukast Sodium Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Montelukast Sodium Market

• 15.1. Western Europe Montelukast Sodium Market Overview
• 15.2. Western Europe Montelukast Sodium Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Montelukast Sodium Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Montelukast Sodium Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Montelukast Sodium Market

• 16.1. UK Montelukast Sodium Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Montelukast Sodium Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Montelukast Sodium Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Montelukast Sodium Market

• 17.1. Germany Montelukast Sodium Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Montelukast Sodium Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Montelukast Sodium Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Montelukast Sodium Market

• 18.1. France Montelukast Sodium Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Montelukast Sodium Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Montelukast Sodium Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Montelukast Sodium Market

• 19.1. Italy Montelukast Sodium Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Montelukast Sodium Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Montelukast Sodium Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Montelukast Sodium Market

• 20.1. Spain Montelukast Sodium Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Montelukast Sodium Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Montelukast Sodium Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Montelukast Sodium Market

• 21.1. Eastern Europe Montelukast Sodium Market Overview
• 21.2. Eastern Europe Montelukast Sodium Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Montelukast Sodium Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Montelukast Sodium Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Montelukast Sodium Market

• 22.1. Russia Montelukast Sodium Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Montelukast Sodium Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Montelukast Sodium Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Montelukast Sodium Market

• 23.1. North America Montelukast Sodium Market Overview
• 23.2. North America Montelukast Sodium Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Montelukast Sodium Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Montelukast Sodium Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Montelukast Sodium Market

• 24.1. USA Montelukast Sodium Market Overview
• 24.2. USA Montelukast Sodium Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Montelukast Sodium Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Montelukast Sodium Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Montelukast Sodium Market

• 25.1. Canada Montelukast Sodium Market Overview
• 25.2. Canada Montelukast Sodium Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Montelukast Sodium Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Montelukast Sodium Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Montelukast Sodium Market

• 26.1. South America Montelukast Sodium Market Overview
• 26.2. South America Montelukast Sodium Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Montelukast Sodium Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Montelukast Sodium Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Montelukast Sodium Market

• 27.1. Brazil Montelukast Sodium Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Montelukast Sodium Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Montelukast Sodium Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Montelukast Sodium Market

• 28.1. Middle East Montelukast Sodium Market Overview
• 28.2. Middle East Montelukast Sodium Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Montelukast Sodium Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Montelukast Sodium Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Montelukast Sodium Market

• 29.1. Africa Montelukast Sodium Market Overview
• 29.2. Africa Montelukast Sodium Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Montelukast Sodium Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Montelukast Sodium Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Montelukast Sodium Market Competitive Landscape And Company Profiles

• 30.1. Montelukast Sodium Market Competitive Landscape
• 30.2. Montelukast Sodium Market Company Profiles
  • 30.2.1. Pfizer Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Merck & Co. Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Sanofi Aventis SA
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Teva Pharmaceuticals USA Inc.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Hetero Labs Ltd.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Montelukast Sodium Market Other Major And Innovative Companies

• 31.1. Sun Pharma Industries Ltd.
• 31.2. Aurobindo Pharma Limited
• 31.3. Cipla Inc.
• 31.4. Intas Pharmaceuticals Ltd.
• 31.5. Seqens Group
• 31.6. Sanyo Chemical Industries Ltd.
• 31.7. Morepen Laboratories
• 31.8. Neuland Laboratories Ltd.
• 31.9. Medopharm Private Ltd.
• 31.10. BEC Chemicals Pvt. Ltd
• 31.11. Delmar Chemicals Inc.
• 31.12. Kimia Biosciences Ltd.
• 31.13. Ortin Laboratories Ltd.
• 31.14. MSN Laboratories Pvt Ltd.
• 31.15. Vamsi Labs Ltd.

32. Global Montelukast Sodium Market Competitive Benchmarking

33. Global Montelukast Sodium Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Montelukast Sodium Market

35. Montelukast Sodium Market Future Outlook and Potential Analysis

• 35.1 Montelukast Sodium Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Montelukast Sodium Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Montelukast Sodium Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer